Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Journal of Perinatology : Official Journal of the California Perinatal Association|June 18, 2004
Immediate changes in lung compliance following natural surfactant administration in premature infants with respiratory distress syndrome: a controlled trialMohammad A Attar, Michael A Becker, Ronald E Dechert, et al.
Inflammatory Bowel Diseases|June 7, 2003
A lupus-like syndrome associated with infliximab therapyJason B Klapman, Daniel Ene-Stroescu, Michael A Becker, et al.
Arthritis Research & Therapy|June 1, 2018
Efficacy and safety of febuxostat extended release and immediate release in patients with gout and moderate renal impairment: phase II placebo-controlled studyLhanoo Gunawardhana, Michael A Becker, Andrew Whelton, et al.
The Journal of Rheumatology|March 17, 2009
Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with goutMichael A Becker, H Ralph Schumacher, Patricia A MacDonald, et al.
ACS Nano|August 3, 2022
Robust Tipless Positioning Device for Near-Field Investigations: Press and Roll Scan (PROscan)Hsuan-Wei Liu, Michael A Becker, Korenobu Matsuzaki, et al.
Nucleosides, Nucleotides & Nucleic Acids|July 5, 2008
Determinants of the clinical outcomes of gout during the first year of urate-lowering therapyMichael A Becker, Patricia A MacDonald, Barbara J Hunt, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 20, 2016
Impact of Febuxostat on Renal Function in Gout Patients With Moderate-to-Severe Renal ImpairmentKenneth G Saag, Andrew Whelton, Michael A Becker, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|November 25, 2014
Infusion-related reactions with pegloticase, a recombinant uricase for the treatment of chronic gout refractory to conventional therapyHerbert S B Baraf, Robert A Yood, Faith D Ottery, et al.
Arthritis and Rheumatism|July 9, 2003
Phosphoribosylpyrophosphate synthetase overactivity as a cause of uric acid overproduction in a young womanPablo García-Pavía, Rosa J Torres, Manuel Rivero, et al.
Life Sciences|February 9, 2005
Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenaseYasuhiro Takano, Kumiko Hase-Aoki, Hideki Horiuchi, et al.
Pageof 6